|0.378||+0.044 / +13.17%|
As of 3:59pm ET
|0.40||+0.022 / +5.82%|
The 1 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +1,222.75% increase from the last price of 0.38.
The current consensus among 1 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.